Timothy Burns, MD, PHD
1 clinical trials · Sponsor
◉ Watch Timothy Burns, MD, PHD
| Record | Firm | Date |
|---|---|---|
| Central Nervous System Efficacy of Capmatinib in NSCLC With Brain Metastases With cfDNA Positive MET Alterations (NCT05567055) | Timothy Burns, MD, PHD | 2023-10-03 |
Track Timothy Burns, MD, PHD automatically
Every clearance here is in the API, with alerts when new ones post.